[HTML][HTML] Invasive candidiasis
PG Pappas, MS Lionakis, MC Arendrup… - Nature Reviews …, 2018 - nature.com
Invasive candidiasis is an important health-care-associated fungal infection that can be
caused by several Candida spp.; the most common species is Candida albicans, but the …
caused by several Candida spp.; the most common species is Candida albicans, but the …
Fungal endocarditis: pathophysiology, epidemiology, clinical presentation, diagnosis, and management
GR Thompson III, JD Jenks, JW Baddley… - Clinical microbiology …, 2023 - Am Soc Microbiol
Fungal endocarditis accounts for 1% to 3% of all infective endocarditis cases, is associated
with high morbidity and mortality (> 70%), and presents numerous challenges during clinical …
with high morbidity and mortality (> 70%), and presents numerous challenges during clinical …
Candidemia and invasive candidiasis
TP McCarty, CM White, PG Pappas - Infectious Disease Clinics, 2021 - id.theclinics.com
Invasive infection caused by Candida species is a condition associated with medical
progress. It is a common health care–associated infection (HAI), and is widely recognized as …
progress. It is a common health care–associated infection (HAI), and is widely recognized as …
Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 …
Background Rezafungin is a next-generation, once-a-week echinocandin in development
for the treatment of candidaemia and invasive candidiasis and for the prevention of invasive …
for the treatment of candidaemia and invasive candidiasis and for the prevention of invasive …
Diagnosis and treatment of invasive candidiasis
N Barantsevich, E Barantsevich - Antibiotics, 2022 - mdpi.com
Candida species, belonging to commensal microbial communities in humans, cause
opportunistic infections in individuals with impaired immunity. Pathogens encountered in …
opportunistic infections in individuals with impaired immunity. Pathogens encountered in …
Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America
It is important to realize that guidelines cannot always account for individual variation among
patients. They are not intended to supplant physician judgment with respect to particular …
patients. They are not intended to supplant physician judgment with respect to particular …
[HTML][HTML] ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients
F Tissot, S Agrawal, L Pagano, G Petrikkos… - …, 2017 - ncbi.nlm.nih.gov
Abstract The European Conference on Infections in Leukemia (ECIL) provides
recommendations for diagnostic strategies and prophylactic, pre-emptive or targeted therapy …
recommendations for diagnostic strategies and prophylactic, pre-emptive or targeted therapy …
Invasive candidiasis
BJ Kullberg, MC Arendrup - New England Journal of Medicine, 2015 - Mass Medical Soc
Despite advances in antifungal therapy, the mortality associated with invasive candidiasis
remains as high as 40%. This review summarizes recent trends and current strategies …
remains as high as 40%. This review summarizes recent trends and current strategies …
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non‐neutropenic adult patients
Clin Microbiol Infect 2012; 18 (Suppl. 7): 19–37 Abstract This part of the EFISG guidelines
focuses on non‐neutropenic adult patients. Only a few of the numerous recommendations …
focuses on non‐neutropenic adult patients. Only a few of the numerous recommendations …
Invasive candidiasis
TP McCarty, PG Pappas - Infectious Disease Clinics, 2016 - id.theclinics.com
Invasive infection due to Candida species is a condition associated with medical progress. It
is a common health care–associated infection and is widely recognized as a major cause of …
is a common health care–associated infection and is widely recognized as a major cause of …